Blog - Page 13 of 39 - Omega Healthcare

News & Blog

Omega Insights
Advancing the Revenue Cycle Through Technology – Executive Sponsor Spotlight

Author: Arnab Sen, Chief Strategy Officer, Omega Healthcare From HealthLeaders Revenue Cycle Technology Week, Nov 13-17, 2023. https://interactive.healthleadersmedia.com/revenue-cycle-tech-week What are the top two challenges revenue

  • Omega Healthcare
  • 18 March

Tumor Tip header image
Tumor Tip of the Week 03-15-2024 Melanoma pT1 cN0

03-15-2024 Melanoma pT1 cN0 Scenario: [Physical exam showed no lymphadenopathy], patient dx on Shave biopsy, went on to have Wide excision Snip from Path Report

  • Omega Healthcare
  • 15 March

Artificial Intelligence in Healthcare: Why it’s important and how to get started

AI in healthcare can help reduce administrative burdens, improve clinical decision-making, and enhance the patient experience. Author: Vijayashree Natarajan, SVP, Head of Technology Where is

  • Omega Healthcare
  • 13 March

Tumor Tip header image
Tumor Tip of the Week-03-08-2024 Kidney Pathologic Stage

Scenario: Renal US: Large left upper pole renal mass measuring up to 8.1 cm. This is considered renal cell carcinoma until proven otherwise. CT Ab/Pelvis:8

  • Omega Healthcare
  • 11 March

Tumor Tip header image
Tumor Tip of the Week-03-01-2024 HPV Associated Histology

Scenario: 2024 Biopsy Cervix +Squamous cell carcinoma, p16+ Question:  How would you assign histology? 8070 Squamous cell carcinoma 8085 Squamous cell carcinoma, HPV Associated Answer: 

  • Omega Healthcare
  • 04 March

Tumor Tip header image
Tumor Tip of the Week-02-23-2024 [Cholangiocarcinoma Tip of the week-revised] see new instructions-Solid Tumor Rules-Other -Table 9a

Scenario: 1-2023 Bx Liver+ Adenocarcinoma Oncologist/GI Multidisciplinary Conference Stage IV (cT2N1M1) intrahepatic cholangiocarcinoma with pulmonary metastases, regional lymphadenopathy, and multifocal hepatic involvement Question:  How should

  • Omega Healthcare
  • 26 February